Skip to main content
. 2024 May 3;4(1):e72. doi: 10.1017/ash.2024.49

Table 5.

Multivariable Regression of Outcomes, by Compliance with Tailored Therapy (Compliant vs reference)

All syndromes combined (n = 252) Pneumonia (n = 86) Intra-abdominal infection (n = 40) UTI (n = 82) Bacteremia (n = 38) C. difficile infection (n = 29)
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) a aOR (95% CI) a aOR (95% CI)
ICU admission 0.51 (0.13–1.97), P = .328 0.67 (0.06–8.09), P = .754 1.02 (0.10–10.36), P = .990 0.15 (0.01–3.07), P = .216
Graft rejection within 30 days
Graft loss within 30 days
CDI with 30 days
Re-admission within 30 days 1.25 (0.38–4.18), P = .708 1.24 (0.11–13.94), P = .864 1.02 (0.10–10.36), P = .990 1.72 (0.12–23.70), P = .685
Mortality at 30 days 0.07 (0.01–0.38), P = . 002 0.14 (0.01–2.56), P = .186
Composite outcome 0.70 (0.24–2.09), P = .526 0.45 (0.05–3.74), P = .458 2.12 (0.37–11.99), P = .396
Hospital LOS –0.4 (–34.1–33.3), P = .981 14.96 (–31.10–61.02), P = .520 –6.88 (–74.94–61.18), P = .841 46.54 (–48.54–141.62), P = .327
a

Adjusted for age and sex only. Odds ratios were unable to be created when the sample size between the two categories (compliant vs non-compliant) was too low.

Bold values denote statistical significance at the p < .05 level.